Newsroom

Sorted by: Latest

-

Samenvatting: BeOne Medicines kondigt financiële resultaten en bedrijfsupdates voor het eerste kwartaal van 2026 aan

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), een wereldwijd oncologiebedrijf, heeft vandaag de financiële resultatenen bedrijfsupdates voor het eerste kwartaal van 2026 bekendgemaakt. John V. Oyler, medeoprichter, voorzitteren CEO van BeOne, verklaarde: "Deze sterke resultaten in het eerste kwartaal bevestigen de voortdurende groei van BeOne als wereldwijd leider in de oncologie, gedreven door een gedisciplineerde commerciële uitvoering en o...
-

Fazeshift Raises $22M to Power the Future of Autonomous Finance

SAN FRANCISCO--(BUSINESS WIRE)--Fazeshift, an AI-native platform deploying autonomous agents to execute end-to-end accounts receivable workflows, today announced $17M in Series A funding, bringing total funding to $22M. The Series A was led by F-Prime, with participation from Gradient (Google’s early-stage AI fund), Y Combinator, Wayfinder, Pioneer Fund, Ritual Capital, and prominent angels. Already automating invoicing, collections, and reconciliation for enterprise finance teams, Fazeshift is...
-

Melqart Asset Management UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)     1 KEY INFORMATION   (a) Full name of discloser: MELQART ASSET MANAGEMENT (UK) LTD (b) Owner or controller of interests and short positions disclosed, if different from 1(a): N/A The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and benefic...
-

Melqart Asset Management UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--    FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY  A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)     1 KEY INFORMATION   (a) Full name of discloser: MELQART ASSET MANAGEMENT (UK) LTD (b) Owner or controller of interests and short positions disclosed, if different from 1(a): N/A The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and ben...
-

Riassunto: BeOne Medicines annuncia i risultati finanziari relativi al primo trimestre 2026 e gli aggiornamenti aziendali

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), azienda globale attiva nel comparto oncologico, oggi ha reso noti i risultati finanziari e gli aggiornamenti aziendali relativi al primo trimestre 2026. John V. Oyler, Co-Founder, Presidente e AD di BeOne, ha dichiarato: "I solidi risultati del primo trimestre rafforzano la costante espansione di BeOne come leader globale nel settore oncologico, basato sull'esecuzione commerciale disciplinata e fo...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Artificial Intelligence UCITS ETF 06.05.2026 FTAI IE000YIQZ0H6 200,002.00 USD 5,623,270.82 28.116  ...
-

The Lincoln Private Market Index: Broader Private Market Trends Were Stable Despite Software-Driven Decline

CHICAGO--(BUSINESS WIRE)--Lincoln International, a global investment banking advisory firm, announced today that the Lincoln Private Market Index (LPMI), an index that tracks changes in the enterprise value of U.S. privately held companies, decreased by 2.2% in Q1, driven primarily by a 7.8% decrease for technology companies (driven by an 8.8% decrease for software companies) and a 1.5% decrease for business services companies while all other industries remained flat or modestly up quarter-over...
-

Elucid’s Plaque-IQ™ Named “Best New Cardiology Technology Solution” in 2026 MedTech Breakthrough Awards Program

BOSTON--(BUSINESS WIRE)--Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, today announced that its Plaque-IQ arterial plaque analysis software has been selected as winner of the “Best New Cardiology Technology Solution” award in the 10th annual MedTech Breakthrough Awards. The awards program is conducted by MedTech Breakthrough, an independent market intelligence organization tha...
-

AccurKardia’s AK+ Guard™ Named “Best New ECG Technology Solution” By MedTech Breakthrough

NEW YORK--(BUSINESS WIRE)--AccurKardia, an innovator in ECG-based diagnostics technology, today announced that AK+ Guard™ has been selected as winner of the “Best New ECG Technology Solution” award in the 10th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the most innovative companies, technologies and products in the global digital health and medical technology market. AI-powered AK+ Guard hyperkale...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF- June 06.05.2026 MJUN LN IE000CO3P697 150,002.00 USD 3,783,422.43 25.223  ...